CUSIP 13463J101COMCAMPQ4 2025
22 filings · latest Mar 11, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 6.31M | $38.81M |
| 2 | 5am Venture Management, LLC | 5.87M | $35.98M |
| 3 | Fmr LLC | 4.92M | $30.15M |
| 4 | Vivo Capital, LLC | 4.25M | $26.03M |
| 5 | Enavate Sciences Gp, LLC | 3.04M | $18.61M |
| 6 | Balyasny Asset Management L.P. | 2.44M | $14.94M |
| 7 | Adage Capital Partners Gp, L.L.C. | 2.18M | $13.37M |
| 8 | A16z Capital Management, L.L.C. | 2.13M | $13.03M |
| 9 |
| 4 | Jan 8, 2026 | Janus Henderson Group PLC | 13G | 12.2% | 6.31M | SEC |
| 5 | Dec 23, 2025 | Enavate Sciences Gp, LLC | 13D/A | 6.0% | — | SEC |
| 6 | Dec 11, 2025 | Coastlands Capital LP | 13G/A | 10.0% | — | SEC |
| 7 | Nov 14, 2025 | Northpond Ventures II, LP | 13G/A | 4.8% | 2.24M | SEC |
| 8 | Nov 14, 2025 | Ah Bio Fund I, L.P. | 13G/A | 4.5% | 2.13M | SEC |
| 9 | Nov 7, 2025 | Fmr LLC | 13G/A | 6.7% | 3.15M | SEC |
| 10 | Oct 7, 2025 | Fmr LLC | 13G | 15.0% | 3.02M | SEC |
See the full Schedule 13D/13G history for Camp4 Therapeutics Corp.
Unlock full history| Trails Edge Capital Partners, LP |
| 1.98M |
| $12.16M |
| 10 | Vanguard Group Inc | 1.67M | $10.26M |